Literature DB >> 2325662

Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification.

D Owerbach1, Y M Crawford, M B Draznin.   

Abstract

Steroid 21-hydroxylase deficiency is the leading cause of impaired cortisol synthesis in congenital adrenal hyperplasia (CAH). We have studied the structure of the CYP21B gene in 30 unrelated CAH patients using the polymerase chain reaction (PCR) to differentiate the active CYP21B gene from its highly related CYP21A pseudogene. The PCR approach obviates the need to distinguish the CYP21A and CYP21B genes by restriction endonuclease digestion and electrophoresis before analysis with labeled probes. Furthermore, direct nucleotide sequence analysis of CYP21B genes is demonstrated on the PCR-amplified DNA. Gene deletion of CYP21B, gene conversion of the entire CYP21B gene to CYP21A, frame shift mutations in exon 3, an intron 2 mutation that causes abnormal RNA splicing, and a mutation leading to a stop codon in exon 8 appear to be the major abnormalities of the CYP21B gene in our patients. These mutations appear to account for 21-hydroxylase deficiency in 22 of 26 of our salt-wasting CAH patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2325662     DOI: 10.1210/mend-4-1-125

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  18 in total

1.  HLADR5 and C4BQO high frequency and antinuclear antibodies positivity in patients with 21 hydroxylase deficiency from Campania region.

Authors:  F Parlato; G Pisano; G Misiano; E Cosentini; C Cacciapuoti; M R Cavalcanti; M Brai; A Bellastella
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

2.  Canadian Mennonites and individuals residing in the Friesland region of The Netherlands share the same molecular basis of 17 alpha-hydroxylase deficiency.

Authors:  T Imai; T Yanase; M R Waterman; E R Simpson; J J Pratt
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

3.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P W Speiser; J Dupont; D Zhu; J Serrat; M Buegeleisen; M T Tusie-Luna; M Lesser; M I New; P C White
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency.

Authors:  E Mornet; P Crété; F Kuttenn; M C Raux-Demay; J Boué; P C White; A Boué
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

5.  Function and membrane topology of wild-type and mutated cytochrome P-450c21.

Authors:  M C Hu; L C Hsu; N C Hsu; B C Chung
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

Review 6.  Molecular pathology of 21-hydroxylase deficiency.

Authors:  T Strachan
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

7.  A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.

Authors:  C A Brosnan; P Brosnan; B L Therrell; C H Slater; J M Swint; J F Annegers; W J Riley
Journal:  Public Health Rep       Date:  1998 Mar-Apr       Impact factor: 2.792

8.  Substitution of Ile-172 to Asn in the steroid 21-hydroxylase B (P450c21B) gene in a Finnish patient with the simple virilizing form of congenital adrenal hyperplasia.

Authors:  J Partanen; R D Campbell
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

9.  Altered CYP21 genes in HLA-haplotypes associated with congenital adrenal hyperplasia (CAH): a family study.

Authors:  B J Manfras; M Swinyard; W A Rudert; E J Ball; P A Lee; P Kühnl; M Trucco; B O Böhm
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

10.  Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism.

Authors:  T Tajima; K Fujieda; K Nakayama; Y Fujii-Kuriyama
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.